Tonnesencho4784

Pediatric cases of a brainstem glioma are one of the most difficult tumors to treat. In children, this type of cancer is perhaps the most dreaded of cancers due to its poor prognosis, yet it remains an area of intense research. In the case presented herein, conventional chemotherapy and radiotherapy treatments were not showing any improvement. The patient was then treated with high-dose intravenous vitamin C (IVC) and endolaser therapy. A significant reduction in glioma's size was achieved in 2 months with this adjunct therapy. These results present a possibility of decreasing brainstem glioma progression with adjuvant IVC and endolaser therapy. © The Author(s) 2020.Background The emphasis on Evidence-Based Practice (EBP) is taking on new importance as the profession of nursing strives to meet the challenge of defining the direction of health care, promoting optimal outcomes, and ensuring patient safety. Therefore, Evidence-Based Practice has never been more important to nursing than in the current health-care environment. Objective The study was designed to assess the knowledge, behaviors, and attitudes of nurses as compared with Evidence-Based Practice in relation to the Guidelines of the European Resuscitation Council. Methods The study covered involved a total of 236 nurses who participated in a cardiopulmonary resuscitation course over a period of 12 months. The nurses who qualified for the study followed a complete study registration procedure. Results The current findings show that the lowest score was achieved in the domain of attitude toward selected Evidence-Based Practice aspects in professional work. Detailed domain questions concerned nurses' Evidence-Based ty to make critical assessments and synthesize evidence should be improved. According to the nurses, clinical experience cannot be the only and the best way to assess the effectiveness of a given measure. © The Author(s) 2019.Introduction Nowadays, during formation and development of medicine, the main sector of health care is the protection of maternity and childhood. According to the Ministry of Health of Ukraine, inflammatory diseases of the reproductive system make up 60-65% of all gynecological diseases, among them inflammation of the fallopian tubes and ovaries is 79,6%, which occurs predominantly at young age. The aim is to study the microscopic structure of the oviducts wall in different anatomical parts during the embryonic period of human ontogenesis. Material and Methods Were studied uterine tubes of the 4-10 months’ embryos. We used a light microscopy method and morphometry to describe the peculiarities of oviducts’ infundibulum, isthmus and ampullary part in fetus from 81 mm to 375 mm PCL. Results The histotopography of the oviducts tunics and its parts (infundibulum, ampullary part, isthmus and uterine part) in the fetal period of ontogenesis is described in the article. The thickness of the oviduct wall in the dynamics of the fetal period increases in the direction from the infundibulum to the uterine part of the tube. The main part of the thickness of the oviduct wall is presented by muscles. The thickness of the circumferential muscle layer predominates over the thickness of the longitudinal in 2.5-2.8 times. Mucosa is thicker the isthmus, thinnest in the ampullary part of the uterine tube. Conclusions The thickness of the infants oviduct wall in the dynamics increases in the direction from its infundibulum to the uterine part. The main part of the thickness of the oviduct wall is the tunica muscularis. The thickness of the circular muscle layer predominates the thickness of the longitudinal 2.5-2.8 times. Mucosa is thicker in the isthmus, the thinnest in the ampullary part. It is expedient to study the histotopography of the oviduct in the neonatal period of human ontogenesis.Inhibitor of apoptosis protein (IAP) antagonists have shown activity in preclinical models of head and neck squamous cell carcinoma (HNSCC), and work across several cancer types has demonstrated diverse immune stimulatory effects including enhancement of T cell, NK cell, and dendritic cell function. However, tumor-cell-intrinsic mechanisms for this immune upregulation have been largely unexplored. In this study, we show that ASTX660, an antagonist of cIAP1/2 and XIAP, induces expression of immunogenic cell death (ICD) markers in sensitive HNSCC cell lines in vitro. Experiments in syngeneic mouse models of HNSCC showed that ASTX660 can also enhance radiation-induced ICD in vivo. On a functional level, ASTX660 also enhanced killing of multiple murine cell lines by cytotoxic tumor-infiltrating lymphocytes, and when combined with XRT, stimulated clonal expansion of antigen-specific T lymphocytes and expression of MHC class I on the surface of tumor cells. Flow cytometry experiments in several human HNSCC cell lines showed that MHC class I (HLA-A,B,C) was reliably upregulated in response to ASTX660 + TNFα, while increases in other antigen processing machinery (APM) components were variable among different cell lines. These findings suggest that ASTX660 may enhance anti-tumor immunity both by promoting ICD and by enhancing antigen processing and presentation. Fluorofurimazine in vivo © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.Background We investigate the role of family history of cancer (FHC) and diagnosis of metachronous and/or synchronous multiple neoplasms (MN), during anti-PD-1/PD-L1 immunotherapy. Design This was a multicenter retrospective study of advanced cancer patients treated with anti-PD-1/PD-L1 immunotherapy. FHC was collected in lineal and collateral lines, and patients were categorized as follows FHC-high (in case of cancer diagnoses in both the lineal and collateral family lines), FHC-low (in case of cancer diagnoses in only one family line), and FHC-negative. Patients were also categorized according to the diagnosis of MN as follows MN-high (>2 malignancies), MN-low (two malignancies), and MN-negative. Objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and incidence of immune-related adverse events (irAEs) of any grade were evaluated. Results 822 consecutive patients were evaluated. 458 patients (55.7%) were FHC-negative, 289 (35.2%) were FHC-low, and 75 (9.1%) FHC-high, respectively.